Clinical Trials · NCT04425746
Afamelanotide as Adjunctive Therapy in Patients Undergoing Photodynamic Therapy (PDT) Utilising Porfimer Sodium
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 16
- Start date
- Aug 2008
- Locations
- See registry
- Primary endpoint
- The First Day on Which Patients Are Free From Symptoms of Phototoxicity Following Phototesting